Sorafenib as a potential strategy for refractory pulmonary arterial hypertension

Gou Kimura, Masaharu Kataoka, Takumi Inami, Keiichi Fukuda, Hideaki Yoshino, Toru Satoh

Research output: Contribution to journalArticlepeer-review

23 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Sorafenib as a potential strategy for refractory pulmonary arterial hypertension'. Together they form a unique fingerprint.

Medicine & Life Sciences

Chemical Compounds